- Home
- RRBI vs DCTH Comparison
RRBI vs DCTH Comparison
Compare RRBI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- DCTH
- Stock Information
- Founded
- RRBI 1998
- DCTH 1988
- Country
- RRBI United States
- DCTH United States
- Employees
- RRBI N/A
- DCTH N/A
- Industry
- RRBI Hotels/Resorts
- DCTH Medical/Dental Instruments
- Sector
- RRBI Consumer Discretionary
- DCTH Health Care
- Exchange
- RRBI Nasdaq
- DCTH Nasdaq
- Market Cap
- RRBI 394.9M
- DCTH 352.0M
- IPO Year
- RRBI 2019
- DCTH N/A
- Fundamental
- Price
- RRBI $55.48
- DCTH $11.01
- Analyst Decision
- RRBI
- DCTH Strong Buy
- Analyst Count
- RRBI 0
- DCTH 4
- Target Price
- RRBI N/A
- DCTH $21.50
- AVG Volume (30 Days)
- RRBI 13.0K
- DCTH 378.5K
- Earning Date
- RRBI 01-28-2025
- DCTH 11-08-2024
- Dividend Yield
- RRBI 0.65%
- DCTH N/A
- EPS Growth
- RRBI N/A
- DCTH N/A
- EPS
- RRBI 4.75
- DCTH N/A
- Revenue
- RRBI $106,383,000.00
- DCTH $22,644,000.00
- Revenue This Year
- RRBI N/A
- DCTH $1,605.13
- Revenue Next Year
- RRBI $7.61
- DCTH $111.67
- P/E Ratio
- RRBI $11.68
- DCTH N/A
- Revenue Growth
- RRBI N/A
- DCTH 945.91
- 52 Week Low
- RRBI $42.78
- DCTH $3.70
- 52 Week High
- RRBI $62.13
- DCTH $13.30
- Technical
- Relative Strength Index (RSI)
- RRBI 40.05
- DCTH 48.00
- Support Level
- RRBI $57.65
- DCTH $10.75
- Resistance Level
- RRBI $58.59
- DCTH $13.30
- Average True Range (ATR)
- RRBI 1.95
- DCTH 0.72
- MACD
- RRBI -0.83
- DCTH -0.13
- Stochastic Oscillator
- RRBI 28.83
- DCTH 10.19
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.